Meet Oakwood Labs at This Year’s Forum on Pharma: Building Better Injectables
Oakwood Labs is happy to announce that we will be participating and presenting at the upcoming Forum on Pharma: Building Better Injectables. The event goes from June 3-5 at the Ashland R&D site in Wilmington, Delaware. If you would like to learn more about the event, please visit the following link: https://solving.ashland.com/pharmaceutical/wilmington-injectable-form-0632025
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 28 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Oakwood will be presenting:
Dr. Tracy Richey (Senior Director of Technology) will be presenting on understanding advanced delivery formulation techniques.
Contact Us for More Information
The Forum on Pharma covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
- PharmaTher and Oakwood Labs Advance Strategy For Next-Generation Ketamine for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program - November 19, 2025
- Exhibiting and Presenting at AAPS 2025 PharmaSci 360 in San Antonio - November 6, 2025
- Learn About Chroniject Technology at the Upcoming PODD Conference - October 23, 2025